Cells at the bottom of a liquid medium begin levitating, then hovering at a particular height. With no physical contact, an ...

Diversified science and technology company Danaher (NYSE:DHR) beat Wall Street’s revenue expectations in Q3 CY2025, with ...

The expansion of the HSV testing market is being fueled by a combination of increasing prevalence of HSV infections, ...

Discover Danaher's strong Q3 results, strategic reinvestments, and biotech growth. See why DHR is poised for future earnings ...

Danaher Corporation ( NYSE: DHR) Q3 2025 Earnings Call October 21, 2025 8:00 AM EDT ...

While quantum phenomena can be demonstrated using experiments such as the Double-Slit Experiment, certifying that a ...

But a new generation of noninvasive tests are emerging that could help accelerate diagnosis and improve management of this ...

Daiichi and Merck saw the highest ORR—57.1%—in patients who received the top dose of R-DXd. Yet the drugmakers have opted to take the middle 5.6 mg/kg dose into the phase 3 part of the trial. The ORR ...